# OnCo record paper-luminosity-j-clin-oncol-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-luminosity-j-clin-oncol-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-luminosity-j-clin-oncol-2024" ;
  schema:name "Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial"@en ;
  schema:description "Published report from the LUMINOSITY trial registered as NCT03539536, in Journal of Clinical Oncology (2024), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-luminosity-j-clin-oncol-2024/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.24.00720>, <https://pubmed.ncbi.nlm.nih.gov/38843488/>, <https://europepmc.org/article/MED/38843488>, <https://clinicaltrials.gov/study/NCT03539536> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.24.00720> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Camidge DR, Bar J, Horinouchi H, et al." ;
  onco:trials <https://onco.cc/trials/luminosity/> ;
  onco:journals <https://onco.cc/journals/jco/> .